83 research outputs found
Models for the size distribution of businesses in a price driven market
A microscopic model of aggregation and fragmentation is introduced to
investigate the size distribution of businesses. In the model, businesses are
constrained to comply with the market price, as expected by the customers,
while customers can only buy at the prices offered by the businesses. We show
numerically and analytically that the size distribution scales like a
power-law. A mean-field version of our model is also introduced and we
determine for which value of the parameters the mean-field model agrees with
the microscopic model. We discuss to what extent our simple model and its
results compare with empirical data on company sizes in the U.S. and debt sizes
in Japan. Finally, possible extensions of the mean-field model are discussed,
to cope with other empirical data.Comment: 12 pages, 2 figures, submitted for publicatio
Strategy Selection in the Minority Game
We investigate the dynamics of the choice of an active strategy in the
minority game. A history distribution is introduced as an analytical tool to
study the asymmetry between the two choices offered to the agents. Its
properties are studied numerically. It allows us to show that the departure
from uniformity in the initial attribution of strategies to the agents is
important even in the efficient market. Also, an approximate expression for the
variance of the number of agents at one side in the efficient phase is
proposed. All the analytical propositions are supported by numerical
simulations of the system.Comment: Latex file, 17 page, 4 figure
Experimental validation of flexibility provision by highly distributed demand portfolio
The wide scale deployment and utilization of demand side management for the provision of frequency balancing service provision is hindered by the lack of proof of performance evaluation of such mechanisms. In this paper, the pre-qualification testing approaches for performance evaluation of frequency balancing service provision by highly distributed demand portfolio are discussed. Preliminary experimental results and challenges that arise of the pre-qualification tests conducted on a highly distributed flexible resource portfolio being managed by a multi-agent based demand side management technology are presented and the need for expansion of present day testing procedures discussed
Demand side participation for frequency containment in the web of cells architecture
A large number of demand side management schemes have been proposed in literature for provision of frequency control ancillary services to the network. However, it is assumed that all the flexible devices within the network are managed and controlled under one demand side management (DSM) scheme. In this paper, two independent demand side management schemes control the portfolio of flexible devices within a web of cells architecture. A methodology and scenarios for analysis of the performance of more than one DSM scheme within the same network have been realized using a real-time power hardware-in-the-loop co-simulation platform, and the paper presents this as a basis for investigations of such arrangements
Overlapping functions of the starch synthases SSII and SSIII in amylopectin biosynthesis in Arabidopsis
Background: The biochemical mechanisms that determine the molecular architecture of
amylopectin are central in plant biology because they allow long-term storage of reduced carbon.
Amylopectin structure imparts the ability to form semi-crystalline starch granules, which in turn
provides its glucose storage function. The enzymatic steps of amylopectin biosynthesis resemble
those of the soluble polymer glycogen, however, the reasons for amylopectin's architectural
distinctions are not clearly understood. The multiplicity of starch biosynthetic enzymes conserved
in plants likely is involved. For example, amylopectin chain elongation in plants involves five
conserved classes of starch synthase (SS), whereas glycogen biosynthesis typically requires only one
class of glycogen synthase.
Results: Null mutations were characterized in AtSS2, which codes for SSII, and mutant lines were
compared to lines lacking SSIII and to an Atss2, Atss3 double mutant. Loss of SSII did not affect
growth rate or starch quantity, but caused increased amylose/amylopectin ratio, increased total
amylose, and deficiency in amylopectin chains with degree of polymerization (DP) 12 to DP28. In
contrast, loss of both SSII and SSIII caused slower plant growth and dramatically reduced starch
content. Extreme deficiency in DP12 to DP28 chains occurred in the double mutant, far more
severe than the summed changes in SSII- or SSIII-deficient plants lacking only one of the two
enzymes.
Conclusion: SSII and SSIII have partially redundant functions in determination of amylopectin
structure, and these roles cannot be substituted by any other conserved SS, specifically SSI, GBSSI,
or SSIV. Even though SSIII is not required for the normal abundance of glucan chains of DP12 to
DP18, the enzyme clearly is capable of functioning in production such chains. The role of SSIII in
producing these chains cannot be detected simply by analysis of an individual mutation.
Competition between different SSs for binding to substrate could in part explain the specific
distribution of glucan chains within amylopectin
Fifteen days of 3200m simulated hypoxia marginally regulates markers for protein synthesis and degradation in human skeletal muscle
Chronic hypoxia leads to muscle atrophy. The molecular mechanisms responsible for this phenomenon are not well defined in vivo. We sought to determine how chronic hypoxia regulates molecular markers of protein synthesis and degradation in human skeletal muscle and whether these regulations were related to the regulation of the hypoxia-inducible factor (HIF) pathway. Eight young male subjects lived in a normobaric hypoxic hotel (FiO2 14.1%, 3,200 m) for 15 days in well-controlled conditions for nutrition and physical activity. Skeletal muscle biopsies were obtained in the musculus vastus lateralis before (PRE) and immediately after (POST) hypoxic exposure. Intramuscular hypoxia-inducible factor-1 alpha (HIF-1α) protein expression decreased (-49%, P=0.03), whereas hypoxia-inducible factor-2 alpha (HIF-2α) remained unaffected from PRE to POST hypoxic exposure. Also, downstream HIF-1α target genes VEGF-A (-66%, P=0.006) and BNIP3 (-24%, P=0.002) were downregulated, and a tendency was measured for neural precursor cell expressed, developmentally Nedd4 (-47%, P=0.07), suggesting lowered HIF-1α transcriptional activity after 15 days of exposure to environmental hypoxia. No difference was found on microtubule-associated protein 1 light chain 3 type II/I (LC3b-II/I) ratio, and P62 protein expression tended to increase (+45%, P=0.07) compared to PRE exposure levels, suggesting that autophagy was not modulated after chronic hypoxia. The mammalian target of rapamycin complex 1 pathway was not altered as Akt, mammalian target of rapamycin, S6 kinase 1, and 4E-binding protein 1 phosphorylation did not change between PRE and POST. Finally, myofiber cross-sectional area was unchanged between PRE and POST. In summary, our data indicate that moderate chronic hypoxia differentially regulates HIF-1α and HIF-2α, marginally affects markers of protein degradation, and does not modify markers of protein synthesis or myofiber cross-sectional area in human skeletal muscle
Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice
<p>Abstract</p> <p>Background</p> <p>We reported that roflumilast, a phosphodiesterase 4 inhibitor, given orally at 5 mg/kg to mice prevented the development of emphysema in a chronic model of cigarette smoke exposure, while at 1 mg/kg was ineffective. Here we investigated the effects of roflumilast on the volume density (V<sub>V</sub>) of the inflammatory cells present in the lungs after chronic cigarette smoke exposure.</p> <p>Methods</p> <p>Slides were obtained from blocks of the previous study and V<sub>V </sub>was assessed immunohistochemically and by point counting using a grid with 48 points, a 20× objective and a computer screen for a final magnification of 580×. Neutrophils were marked with myeloperoxidase antibody, macrophages with Mac-3, dendritic cells with fascin, B-lymphocytes with B220, CD4+ T-cells with CD4+ antibody, and CD8+T-cells with CD8-α. The significance of the differences was calculated using one-way analysis of variance.</p> <p>Results</p> <p>Chronic smoke exposure increased neutrophil V<sub>V </sub>by 97%, macrophage by 107%, dendritic cell by 217%, B-lymphocyte by 436%, CD4+ by 524%, and CD8+ by 417%. The higher dose of roflumilast prevented the increase in neutrophil V<sub>V </sub>by 78%, macrophage by 82%, dendritic cell by 48%, B-lymphocyte by 100%, CD4+ by 98% and CD8+ V<sub>V </sub>by 88%. The lower dose of roflumilast did not prevent the increase in neutrophil, macrophage and B-cell V<sub>V </sub>but prevented dendritic cells by 42%, CD4+ by 55%, and CD8+ by 91%.</p> <p>Conclusion</p> <p>These results indicate (<it>i</it>) chronic exposure to cigarette smoke in mice results in a significant recruitment into the lung of inflammatory cells of both the innate and adaptive immune system; (<it>ii</it>) roflumilast at the higher dose exerts a protective effect against the recruitment of all these cells and at the lower dose against the recruitment of dendritic cells and T-lymphocytes; (<it>iii</it>) these findings underline the role of innate immunity in the development of pulmonary emphysema and (<it>iiii</it>) support previous results indicating that the inflammatory cells of the adaptive immune system do not play a central role in the development of cigarette smoke induced emphysema in mice.</p
The effect of cigarette smoke exposure on the development of inflammation in lungs, gut and joints of TNFΔARE mice
The inflammatory cytokine TNF-alpha is a central mediator in many immune-mediated diseases, such as Crohn's disease (CD), spondyloarthritis (SpA) and chronic obstructive pulmonary disease (COPD). Epidemiologic studies have shown that cigarette smoking (CS) is a prominent common risk factor in these TNF-dependent diseases. We exposed TNF Delta ARE mice; in which a systemic TNF-alpha overexpression leads to the development of inflammation; to 2 or 4 weeks of air or CS. We investigated the effect of deregulated TNF expression on CS-induced pulmonary inflammation and the effect of CS exposure on the initiation and progression of gut and joint inflammation. Upon 2 weeks of CS exposure, inflammation in lungs of TNF Delta ARE mice was significantly aggravated. However, upon 4 weeks of CS-exposure, this aggravation was no longer observed. TNF Delta ARE mice have no increases in CD4+ and CD8+ T cells and a diminished neutrophil response in the lungs after 4 weeks of CS exposure. In the gut and joints of TNF Delta ARE mice, 2 or 4 weeks of CS exposure did not modulate the development of inflammation. In conclusion, CS exposure does not modulate gut and joint inflammation in TNF Delta ARE mice. The lung responses towards CS in TNF Delta ARE mice however depend on the duration of CS exposure
- …